Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

MABC1824

Sigma-Aldrich

Anti-phospho-MYO10 (Ser1060/1062/1066) Antibody, clone 2C10-6

Synonym(e):

Unconventional myosin-10, Unconventional myosin-X

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352203
NACRES:
NA.41

Biologische Quelle

mouse

Qualitätsniveau

Antikörperform

purified antibody

Antikörper-Produkttyp

primary antibodies

Klon

2C10-6, monoclonal

Mol-Gew.

calculated mol wt 237.35 kDa
observed mol wt ~260 kDa

Aufgereinigt durch

using protein G

Speziesreaktivität

human

Verpackung

antibody small pack of 100 μL

Methode(n)

immunocytochemistry: suitable
western blot: suitable

Isotyp

IgG1κ

Epitopsequenz

Unknown

Protein-ID-Hinterlegungsnummer

UniProt-Hinterlegungsnummer

Lagertemp.

2-8°C

Angaben zum Gen

human ... MYO10(4651)

Allgemeine Beschreibung

Unconventional myosin-X (UniProt: Q9HD67; also known as Unconventional myosin-10, MYO10) is encoded by the MYO10 (also known as KIAA0799) gene (Gene ID:4651) in human. Myosins are highly conserved, ubiquitously expressed proteins that form regular bipolar thick filaments that together with actin thin filaments constitute the fundamental contractile unit of skeletal and cardiac muscle. Along with actin they serve as motor molecules with ATPase activity that is essential for muscle contraction. MYO10, a multi-domain protein, is ubiquitously expressed and is present as a monomer in the cytosol in an inactive conformation. However, it is homodimeric in its active, membrane-bound conformation. It interacts strongly with calmodulin 3 (CALM3) and this interaction is essential for its function in filopodial extension and motility. It contains a MyTH4 and an FERM domain at its C-terminal, which are required for its binding to tubulin and β-integrin, respectively. The N-terminal region contains a sequence (aa 619-641) that is required for its bind to actin. Its myosin motor domain is localized in amino acids 63-739. MYO10 is reported to promote tumor growth through inducing genomic instability and chronic inflammation in cancer cells. It regulates genomic instability, at least partially, through mediating mitotic progression. MYO10 is reported to contain a Degron motif, a short stretch of amino acids that drives the degradation of unstable protein. In addition, phosphorylation of serine residues in MYO10 (serine 1060, 1062, 1066) drives its β-TrCP1-dependent degradation. Phosphorylated form of MYO10 is shown to be less stable. Degron mutation are reported to abolish MYO10 phosphorylation, degradation, and mitotic regulation. Cancer cells expressing high levels or stabilized MYO10 display higher sensitivity to Taxol. Deletion of Degron motif results in complete stability of MYO10. (Ref.: Pozo, MF., et al. (2023). Cell Rep. 42(5); 112531; Pozo, MF., et al. (2021). Sci Adv. 7(38); eabg6908).

Spezifität

Clone 2C10-6 is a mouse monoclonal antibody that detects MY10 phosphorylated on serine 1060, 1062, and 1066.

Immunogen

KLH-conjugated linear peptide corresponding to 13 amino acids surrounding phosphoserines 1060, 1062, and 1066 from human MYO10.

Anwendung

Quality Control Applications

Evaluated by Western Blotting in lysate U20S cells transfected with GFP-MYO10.

Western Blotting Analysis (WB): A 1:250 dilution of this antibody detected phospho-MYO10 (Ser 1060/1062/1066) in U20S cells stably transfected with GFP-MYO10, but not in lysate from cells with MYO10 knockout.

Tested applications

Immunocytochemistry Analysis: A representative lot detected p-MYO10 (Ser1060/1062/1066) in Immunocytochemistry application (Pozo, F. M., et al. (2021). Sci Adv. 7(38); eabg6908).

Western Blotting Analysis: A representative lot detected p-MYO10 (Ser1060/1062/1066) in Western Blotting application (Pozo, F. M., et al. (2021). Sci Adv. 7(38); eabg6908).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Physikalische Form

Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Lagerung und Haltbarkeit

Recommended storage: +2°C to +8°C.

Sonstige Hinweise

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sie haben nicht das passende Produkt gefunden?  

Probieren Sie unser Produkt-Auswahlhilfe. aus.

Lagerklassenschlüssel

13 - Non Combustible Solids

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.